| EVOTEC AG : Evotec and Harvard University Expand Strategic Alliance into ... - 4-traders (press release) |
|
|
4-traders (press release) Patients with end stage renal disease (ESRD) suffer from complete loss of kidney function and have to be treated by dialysis, a costly and burdensome procedure with limited efficacy and generally poor prognosis. Novel therapeutic approaches are needed |